Claypoole Robert E bought BVS
January 11, 2024 · Form 4 insider transaction
Claypoole Robert E bought 375,000 shares of Bioventus Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
375,000
Price
$0.00
Total value
N/A
InsiderClaypoole Robert E
Role—
CompanyBioventus Inc. (BVS)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJanuary 11, 2024
Filing dateJanuary 12, 2024
Shares owned after375,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Class A common stock.; The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.